You are here

Prices & Quotes - UK Markets - Feedback (FDBK)

Risk Warning The value of investments can fall as well as rise and any income from them is not guaranteed and you may get back less than you invested. Past performance is not a guide to future performance.

Share Price:
Down 0.80p
Change Today:
-0.025p
Market Cap:
21.34m
Sector:
Health Care Equipment & Services

Feedback's Bleepa chosen by CVS equine division

By Josh White

Date: Friday 16 Jul 2021

LONDON (ShareCast) - (Sharecast News) - Medical imaging technology company Feedback announced on Friday that UK veterinary provider CVS Group has appointed 'Bleepa' as its clinical communications platform for its equine division.
The AIM-traded firm said that, following a successful pilot trial, CVS had adopted Bleepa for initial use in the division, with the platform to be rolled-out across 20 equine specialist surgeries.

It said the current agreement would result in increased Bleepa users, and provide scope for a broader relationship with CVS.

Additionally, the Feedback board said the deal highlighted the scalability of Bleepa, and the company's ability to target non-NHS markets by tailoring the platform.

As part of the pilot, Feedback worked with CVS to adapt Bleepa, providing the features needed for veterinary service, both within the surgery and in the field.

Feedback said that previously, vets were not able to easily acquire x-rays in a field and share them with colleagues.

Bleepa developed an image push capability that enabled x-rays to be "securely pushed" from the x-ray machine over a cellular network to the Bleepa platform.

The platform then made these images available to specialists for immediate review and discussion, allowing the correct treatment guidance for the injured animal to be communicated to the vet and be provided at first visit.

That capability meant that images could now be taken "in any location", and could be "instantly shared" with specialist colleagues for timely advice and guidance.

Feedback said the technology had "clear applications" in both military and rural care delivery in developing countries.

"CVS is an important partner for Feedback and we are delighted to now be working with them officially," said chief executive officer Tom Oakley.

"Their validation of our technology and expertise demonstrates the flexibility of Bleepa within new markets.

"By purchasing Bleepa, CVS have evidenced a real commitment to empower their vets by connecting them with specialist colleagues at the point of care, ultimately resulting in excellent animal care at the touch of a button, anywhere in the world."

At 1351 BST, shares in Bleepa were up 2.42% at 0.85p.

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

 

Feedback Market Data

Currency UK Pounds
Price 0.80p
Change Today -0.025p
52 Week High 1.40p
52 Week Low 0.62p
Volume 2,333,841
Shares Issued 2,666.93m
Market Cap 21.34m
Beta 0.03

Performance Indicators

Compare performance with the sector and the market.

Key
Vs Market
Vs Sector
Value
market
  1. full market star
  2. empty market
  3. empty market
  4. empty market
  5. empty market
sector
  1. full sector star
  2. full sector star
  3. empty sector
  4. empty sector
  5. empty sector
Price Trend
market
  1. full market star
  2. empty market
  3. empty market
  4. empty market
  5. empty market
sector
  1. full sector star
  2. half sector star
  3. empty sector
  4. empty sector
  5. empty sector
Income
Not Available
Growth
market
  1. full market star
  2. empty market
  3. empty market
  4. empty market
  5. empty market
sector
  1. full sector star
  2. empty sector
  3. empty sector
  4. empty sector
  5. empty sector
Price Chg 6m
market
  1. full market star
  2. full market star
  3. empty market
  4. empty market
  5. empty market
sector
  1. full sector star
  2. full sector star
  3. full sector star
  4. empty sector
  5. empty sector
P/E
Not Available
PEG
market
  1. full market star
  2. half market star
  3. empty market
  4. empty market
  5. empty market
sector
  1. full sector star
  2. full sector star
  3. half sector star
  4. empty sector
  5. empty sector
Dividend Yield
Not Available
EPS Growth
Not Available
Operating Margin
market
  1. empty market
  2. empty market
  3. empty market
  4. empty market
  5. empty market
sector
  1. half sector star
  2. empty sector
  3. empty sector
  4. empty sector
  5. empty sector

What The Brokers Say

Strong Buy 1
Buy 0
Neutral 0
Sell 0
Strong Sell 0
Total 1
strong_buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

Feedback Dividends

No dividends found

Trades for 21-Jan-2022

Time Volume / Share Price
15:45 17,627 @ 0.84p
15:32 95,185 @ 0.81p
12:46 25,000 @ 0.81p
12:18 254,827 @ 0.83p
10:29 41,202 @ 0.85p

Feedback Key Personnel

CEO Tom Oakley
CFO Anesh Patel